Yang Y, Liu X, Wei J, Qin J, et al. In vivo expression of CD3/CD19 bispecific T-cell engager and alpha-PD-L1-Fc enables effective and durable immunotherapy for CD19(+)/PD-L1(+) leukemia. Leukemia 2025 Dec 23. doi: 10.1038/s41375-025-02832.
PMID: 41436638